Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-041301
Filing Date
2025-03-18
Accepted
2025-03-18 16:45:04
Documents
2
Period of Report
2025-03-13

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 11432
2 EX-24.1 crbp-ex24_1.htm EX-24.1 9873
  Complete submission text file 0000950170-25-041301.txt   22840
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CORBUS PHARMACEUTICALS HOLDINGS, INC 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address
Hodgson Ian (Reporting) CIK: 0002057525 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37348 | Film No.: 25749103